What Led To Nearly 15% Decline In Merck’s Revenues & EBITDA In The Last 5 Years?
Merck’s Revenue And EBITDA Declined By ~15% In The Last 5 Years Due To Key Patent Losses
Have more questions about Merck? See the links below.
- What’s Merck’s Revenue And Earnings Breakdown In Terms Of Therapeutic Areas?
- What’s Merck’s Fundamental Value Based On Expected 2015 Results?
- How Has Merck’s Revenue Composition Changed In The Last 5 Years?
Notes:
See More at Trefis | View Interactive Institutional Research (Powered by Trefis)